Personalized combination of neoadjuvant domatinostat, nivolumab and ipilimumab in macroscopic stage III melanoma patients stratified according to the interferon-gamma signature: The DONIMI study.
暂无分享，去创建一个
A. Broeks | R. Scolyer | O. Krijgsman | E. Rozeman | C. Blank | S. Cornelissen | G. Long | P. Dimitriadis | A. Spillane | A. Menzies | L. Bosch | J. Versluis | A. C. Akkooi | I. Reijers | B. Wiel | L. Grijpink-Ongering | J. Bouwman | Disha Rao | Maria Gonzalez | M. Dijk